ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,116.17
0.32%
US Tech 100
17,315.60
0.44%
다우존스 지수
38,386.09
0.38%
Bitcoin
64,432.26
0.93%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Outlook Therapeutics Inc (OTLK)

  7. Outlook Therapeutics Inc (OTLK) 뉴스

OTLK Outlook Therapeutics Inc

8.95
0.52 (6.17%)
30 4월(4) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Outlook Therapeutics Inc OTLK 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.52 6.17% 8.95 08:59:53
개장가 저가 고가 종가 전일 종가
8.35 8.35 9.19 9.10 8.43
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
29/04/202422:00GLOBEOutlook Therapeutics® to Present at the Ophthalmology..
16/04/202405:15GLOBEOutlook Therapeutics® Announces Closing of Private Placement..
22/03/202420:35GLOBEOutlook Therapeutics® Receives European Union Positive CHMP..
19/03/202406:10GLOBEOutlook Therapeutics® Announces Closing of Private Placement..
12/03/202421:05GLOBEOutlook Therapeutics® Announces Effective Date for 1-for-20..
12/03/202405:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/03/202406:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/03/202406:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/03/202406:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/03/202406:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/03/202406:16EDGAR2Form 8-K - Current report
15/02/202407:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/02/202406:40EDGAR2Form 8-K - Current report
14/02/202422:05GLOBEOutlook Therapeutics® Reports Financial Results for First..
08/02/202421:00EDGAR2Form ARS - Annual Report to Security Holders
08/02/202420:59EDGAR2Form DEF 14A - Other definitive proxy statements
01/02/202406:01EDGAR2Form SC 13D/A - General statement of acquisition of..
31/01/202422:05GLOBEOutlook Therapeutics® Doses First Subject in NORSE EIGHT
30/01/202407:00EDGAR2Form PRE 14A - Other preliminary proxy statements
25/01/202407:00EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
24/01/202420:02EDGAR2Form 8-K - Current report
23/01/202422:00GLOBEOutlook Therapeutics® Receives FDA Agreement Under Special..
23/12/202307:00EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
23/12/202306:15EDGAR2Form 8-K - Current report
22/12/202322:05GLOBEOutlook Therapeutics® Reports Financial Results for Fiscal..
19/12/202322:05GLOBEOutlook Therapeutics® Submits Special Protocol Assessment..
18/12/202319:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
07/12/202307:00EDGAR2Form 8-K - Current report
06/12/202322:05GLOBEOutlook Therapeutics® Announces Strategic Organizational..
04/12/202319:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
30/11/202306:01EDGAR2Form SC 13D/A - General statement of acquisition of..
28/11/202319:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
27/11/202322:05GLOBEOutlook Therapeutics® Announces Receipt of Type A Meeting..
21/11/202319:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
14/11/202322:05GLOBEOutlook Therapeutics® Adds Global Commercial Expertise with..
14/11/202319:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
02/11/202321:12EDGAR2Form 8-K - Current report
02/11/202321:05GLOBEOutlook Therapeutics® Provides Update on Type A Meetings..
01/11/202321:05GLOBEOutlook Therapeutics® to Present at Guggenheim’s 5th Annual..
21/10/202306:00EDGAR2Form 8-K - Current report
06/10/202306:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/10/202306:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/10/202306:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/10/202306:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/09/202321:05GLOBEOutlook Therapeutics® Requests Type A Meeting With FDA
21/09/202321:05GLOBEOutlook Therapeutics® to Present at the 2023 Cantor..
05/09/202321:05GLOBEOutlook Therapeutics® to Present at the H.C. Wainwright 25th..
30/08/202319:21EDGAR2Form 8-K - Current report
30/08/202319:00GLOBEOutlook Therapeutics® Provides Regulatory Update on FDA..
26/08/202305:31EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]

최근 히스토리

NASDAQ
OTLK
Outlook Therapeutics
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유